Healthcare - Biotechnology - NASDAQ - US
$ 1.84
-3.16 %
$ 138 M
Market Cap
-2.09
P/E
Price Target
Average
180.80%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
15.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Context Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for CNTX of $5.17 , with forecasts ranging from a low of $4.5 to a high of $6 .
CNTX Lowest Price Target
Wall Street Target
4.5 USD
144.57%
CNTX Average Price Target
Wall Street Target
5.17 USD
180.80%
CNTX Highest Price Target
Wall Street Target
6 USD
226.09%
REVENUE FORECAST
Revenue Forecast Chart CNTX
EBIT FORECAST
EBIT Forecast Chart CNTX
NET INCOME FORECAST
Net Income Chart CNTX